Homology Medicines announces publication of in vivo gene editing data with nuclease-free technology
BEDFORD, Mass., July 16, 2018 - Homology Medicines, Inc., a genetic medicines company, announced today a peer-reviewed publication demonstrating that Homology's technology induces efficient and...







